Results 131 to 140 of about 7,687,257 (287)

Ohio Cancer Incidence Surveillance System cancer report

open access: yes, 2003
Quarterly; Electronic coverage as of July 18, 2008: Mar. 2003-Dec. 2003; Spring 2004-Summer 2005.; Description based on: Mar. 2003; title from caption (viewed on July 18, 2008).; No issues published for Fall 2004-Spring 2005.; Harvested from the web on 7/
Ohio Cancer Incidence Surveillance System.
core  

Neurologic Manifestations of Long COVID Affect Adult Females More Severely Than Males

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To characterize differences in neurologic manifestations of postacute sequelae of SARS‐CoV‐2 infection (Neuro‐PASC) between females and males. Methods Cross‐sectional study of the first consecutive 261 posthospitalization Neuro‐PASC (PNP) and 2068 nonhospitalized Neuro‐PASC (NNP) patients evaluated at the Neuro‐COVID clinic between ...
Hannah Kopinsky   +5 more
wiley   +1 more source

United States cancer statistics :2003 incidence and mortality [PDF]

open access: yes
U.S. Cancer Statistics Working Group."December 2006."Editors: Cheryll J. Cardinez ... et al."United States Cancer Statistics: 2003 Incidence and Mortality is a joint publication of the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia;

core  

Predictive Value of Composite Inflammatory Markers for Stroke Prognosis: A Prospective Cohort Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Novel composite inflammatory markers' role in stroke prognosis is understudied, and the best predictor is unclear, requiring further exploration. Objectives This study aimed to systematically evaluate the associations of 6 novel composite inflammatory markers on stroke prognosis.
Bing Wu   +7 more
wiley   +1 more source

Incidence of Malignant Mesothelioma [PDF]

open access: yes
Mesothelioma is a cancer that forms in the tissue that lines many internal organs. The rate of new mesothelioma cases is going down because fewer people are exposed to asbestos.Mesothelioma is a cancer that forms in the mesothelium, the thin tissue that ...

core  

Disease Course After Anti‐CD20 Discontinuation in Secondary Progressive Multiple Sclerosis—A Multicenter Long‐Term Longitudinal Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To describe long‐term outcomes after anti‐CD20 discontinuation in selected patients with secondary progressive multiple sclerosis (SPMS) who remained without subsequent disease‐modifying therapy (DMT). Methods We retrospectively analyzed data from four centers in Austria and Switzerland.
Ferdinand Otto   +12 more
wiley   +1 more source

Invasive Cancer Incidence, 2004\u20132013, and Deaths, 2006\u20132015, in Nonmetropolitan and Metropolitan Counties \u2014 U.S.

open access: yes
Problem/Condition: Previous reports have shown that persons living in nonmetropolitan (rural or urban) areas in the U.S. have higher death rates from all cancers combined than persons living in metropolitan areas.

core   +1 more source

Vascular Disease, Non‐Steroidal Anti‐Inflammatory Drugs and Risk of Parkinson's Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives A history of vascular disease has been shown to be associated with an increased risk of Parkinson's disease, but this may be due to reverse causation. In addition, non‐steroidal anti‐inflammatory drugs are thought to reduce Parkinson's disease risk, but evidence is inconsistent and confounding by prior vascular disease is possible ...
Clare Wotton   +4 more
wiley   +1 more source

Cancer incidence and 5-year survival among Asian/Pacific Islanders, United States\u20142008\u20132017

open access: yes
During 2008 to 2017, cancer incidence rates among the Asian/Pacific Islander population decreased from 338.2 to 285.4 cases per 100,000 males compared with 294.6 to 287.4 cases per 100,000 females.Suggested citation: Centers for Disease Control and ...

core  

Anti‐CD20 Discontinuation Versus Continuation in People Aged Over 50 With Non‐Active Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To determine whether discontinuing anti‐CD20 therapy in people with relapsing‐onset MS aged over 50 is associated with an increased risk of relapse, inflammatory activity, confirmed disability accrual, and serious infection compared with continuing therapy.
Alexia Moukhine   +40 more
wiley   +1 more source

Home - About - Disclaimer - Privacy